Back to 
TUDOR INVESTMENT CORP ET AL
TUDOR INVESTMENT CORP ET AL
AR2
Showing 0 of 2 quarters
Position history for TUDOR INVESTMENT CORP ET AL's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Tudor Investment held 371,306 shares of AR2 (Array Biopharma), worth $17.2M. AR2 was 0.5% of Tudor Investment's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.